#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma pancreas Chemical burn Lymphatic malformation Type IIa hyperlipidaemia Infantile apnoea Urethral valves Mitochondrial encephalomyopathy Congenital pseudarthrosis Superficial vein thrombosis Immunoglobulin G4 related disease Adenomatous polyposis coli Thalassaemia beta Burkitt's lymphoma refractory Neuroendocrine carcinoma Fabry's disease More trials…

    Learn about Rare Diseases

    Netherton’s syndrome Paraneoplastic neurological syndrome – Treatment Myelodysplastic syndrome – Treatment Angiosarcoma recurrent – Treatment Urea cycle disorder – Life with Disease Mast cell activation syndrome – Treatment Cholangitis sclerosing – Trials in Disease Breast angiosarcoma Angiosarcoma non-metastatic – Trials in Disease Pulmonary sarcoidosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CHONDROITIN SULFATE SODIUM Rezpegaldesleukin Osteodex Human Mesenchymal Stem Cells Pioglitazone Calcium Oxybate Arsenic Trioxide Bisacodyl Levamisole Hydrochloride 68Ganota-Anti-Her2 Vhh1 Alpelisib Apl-101 Crofelemer Gefurulimab Citalopram Hydrobromide Toripalimab Betamethasone Dipropionate Capivasertib Elacestrant OMTX705 More therapies…

    Learn about Your Condition

    Arteriovenous malformation Meniere's disease Ovarian cancer recurrent Measles Shprintzen-Goldberg syndrome Adrenogenital syndrome Retinopathy of prematurity Chronic fatigue syndrome Renal failure Premature baby Mitochondrial myopathy Dermatomyositis Rectal adenocarcinoma Adenosquamous cell lung cancer Retinal vein occlusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Use of 68Ga-FAPI-46 and Fludeoxyglucose (18F) for Diagnosing Pleural Mesothelioma in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    Denmark

  • Study on Heart Function Changes in Cancer Patients Treated with Nivolumab or Pembrolizumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Nivolumab
    • Pembrolizumab
    France

  • Study on Letermovir for Preventing Cytomegalovirus in Stem Cell Transplant Patients with CMV-Positive Donors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Cytomegalovirus infection
    Investigated Drugs:
    • Letermovir
    Spain

  • Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Givinostat
    Belgium Italy The Netherlands

  • Study of dabrafenib and trametinib combination therapy before and after surgery in patients with BRAF-mutated anaplastic thyroid cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Dabrafenib
    • Trametinib
    The Netherlands

  • Study on Ruxolitinib for Treating Inclusion Body Myositis in Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Inclusion body myositis
    Investigated Drugs:
    • Ruxolitinib
    France
Previous Page
1 … 393 394 395 396 397 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!